We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
Tudor Investment Corp
26
Tudor Investment Corp
Connecticut
– -$60.6M -279,500 Closed
Loomis, Sayles & Company
27
Loomis, Sayles & Company
Massachusetts
– -$59M -272,007 Closed
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
– -$56.4M -259,796 Closed
BlackRock
29
BlackRock
New York
– -$56.3M -259,600 Closed
WCMNY
30
Westchester Capital Management (New York)
New York
– -$55.1M -253,848 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– -$54.4M -250,719 Closed
Mirae Asset Global Investments
32
Mirae Asset Global Investments
South Korea
– -$52.1M -240,205 Closed
MAM
33
Melqart Asset Management
United Kingdom
– -$50.9M -234,650 Closed
Hudson Bay Capital Management
34
Hudson Bay Capital Management
Connecticut
– -$48.3M -222,597 Closed
Federated Hermes
35
Federated Hermes
Pennsylvania
– -$47.7M -220,000 Closed
MGIM
36
M&G Investment Management
United Kingdom
– -$44.9K -206,703 Closed
Man Group
37
Man Group
United Kingdom
– -$42.7M -197,078 Closed
BHMP
38
Bardin Hill Management Partners
New York
– -$36.9M -170,108 Closed
CS
39
Credit Suisse
Switzerland
– -$35.2M -162,061 Closed
AII
40
AGF Investments Inc
Ontario, Canada
– -$30.4M -140,229 Closed
PMAM
41
Picton Mahoney Asset Management
Ontario, Canada
– -$30.2M -139,360 Closed
DKCM
42
Davidson Kempner Capital Management
New York
– -$29.7M -136,715 Closed
CS
43
Candriam SCA
Luxembourg
– -$14.5M -130,547 Closed
AA
44
AQR Arbitrage
Connecticut
– -$26.9M -124,215 Closed
AllianceBernstein
45
AllianceBernstein
Tennessee
– -$26.9M -123,907 Closed
FTCM
46
First Trust Capital Management
Illinois
– -$23M -105,822 Closed
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– -$22.6M -104,279 Closed
SG Americas Securities
48
SG Americas Securities
New York
– -$21.7M -100,065 Closed
Alyeska Investment Group
49
Alyeska Investment Group
Illinois
– -$21.7M -100,000 Closed
Verition Fund Management
50
Verition Fund Management
Connecticut
– -$21.6M -99,475 Closed
1
2
3 4 5

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.